Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA expands use of Imbruvica to treat rare form of blood cancer
FDA expands use of Imbruvica to treat rare form of blood cancer
FDA expands use of Imbruvica to treat rare form of blood cancer
Submitted by
admin
on January 29, 2015 - 7:19pm
Source:
Yahoo/Reuters
News Tags:
FDA
Imbruvica
JNJ
Pharmacyclics
blood cancer
Waldenstrom's Macroglobulinemia
Headline:
FDA expands use of Imbruvica to treat rare form of blood cancer
Do Not Allow Advertisers to Use My Personal information
